InChI=1S/C28H34O14/c29- 12- 20- 23(41- 21(34) 8- 4- 16- 3- 7- 18(32) 19(33) 11- 16) 22(35) 24(42- 27- 25(36) 28(37,13- 30) 14- 39- 27) 26(40- 20) 38- 10- 9- 15- 1- 5- 17(31) 6- 2- 15/h1- 8,11,20,22- 27,29- 33,35- 37H,9- 10,12- 14H2/b8- 4+/t20- ,22+,23- ,24- ,25+,26- ,27+,28- /m1/s1 |
TXTPNFUSMTWSFE-JCJVHILYSA-N |
[H] [C@] 1(OC[C@] (O) (CO) [C@H] 1O) O[C@@H] 1[C@@H] (O) [C@H] (OC(=O) \C=C\c2ccc(O) c(O) c2) [C@@H] (CO) O[C@H] 1OCCc1ccc(O) cc1 |
|
Lepisorus contortus
(NCBI:txid699669)
|
Found in
whole plant
(BTO:0001461).
95% EtOH extract of air-dried, powdered whole plant
See:
PubMed
|
EC 1.14.14.14 (aromatase) inhibitor
An EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor which interferes with the action of aromatase (EC 1.14.14.14) and so reduces production of estrogenic steroid hormones.
NF-kappaB inhibitor
An inhibitor of NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells), a protein complex involved in the transcription of DNA.
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
|
|
View more via ChEBI Ontology
Outgoing
|
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
has role
EC 1.14.14.14 (aromatase) inhibitor
(CHEBI:50790)
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
has role
NF-κB inhibitor
(CHEBI:73240)
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
has role
plant metabolite
(CHEBI:76924)
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
is a
β-D-glucoside
(CHEBI:22798)
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
is a
alkyl caffeate ester
(CHEBI:65331)
β- (4- hydroxyphenyl)ethyl- 4- O- E- caffeoyl- O- [β- D- apiofuranosyl- (1→2)]- β- D- glucopyranoside
(CHEBI:68340)
is a
phenylethanoid
(CHEBI:74644)
|
|
2- (4- hydroxyphenyl)ethyl 2- O- [(2S,3R,4R)- 3,4- dihydroxy- 4- (hydroxymethyl)tetrahydrofuran- 2- yl]- 4- O- [(2E)- 3- (3,4- dihydroxyphenyl)prop- 2- enoyl]- β- D- glucopyranoside
|
Yang JH, Kondratyuk TP, Jermihov KC, Marler LE, Qiu X, Choi Y, Cao H, Yu R, Sturdy M, Huang R, Liu Y, Wang LQ, Mesecar AD, van Breemen RB, Pezzuto JM, Fong HH, Chen YG, Zhang HJ (2011) Bioactive compounds from the fern Lepisorus contortus. Journal of natural products 74, 129-136 [PubMed:21261296] [show Abstract] Phytochemical investigation of the whole plant of Lepisorus contortus (Christ) Ching led to the isolation of five new phenylethanoid glycosides (1-5), each containing a caffeoyl group, a new flavonoid glycoside (10), and 14 known compounds (6-9 and 11-15, syringic acid, vanillic acid, phloretic acid, diplopterol, and β-sitosterol). This is the first report of phenylethanoid glycosides from the family Polypodiaceae. Compounds 1-15 were evaluated for their cancer chemopreventive potential based on their ability to inhibit tumor necrosis factor alpha (TNF-α)-induced NF-κB activity, nitric oxide (NO) production, and aromatase, quinone reductase 2 (QR-2), and COX-1/-2 activities. Quercetin-3-O-β-d-glucoside (15) demonstrated inhibition against QR2 with an IC(50) value of 3.84 μM, which confirmed kaempferol/quercetin glycosides as the active compounds to inhibit QR2. The compound also demonstrated NF-κB activity with an IC(50) value of 33.6 μM. In addition, compounds 1, 2, 4, and 6 showed aromatase activity with IC(50) values of 30.7, 32.3, 26.8, and 35.3 μM, respectively. |
|